Nearly 14,000 medical professionals made their way to ATS 2022, The American Thoracic Society‘s annual conference designed to showcase the field’s latest advances and spark collaborations. And while many of the topics addressed were heavy, the nonprofit successfully injected some lightheartedness into the experience with a fun zone sponsored by prescription medicine brand Yupelri. Keep reading for a glimpse into the space:
The focal point of the fun zone was Urban Hoops, a city inspired basketball game gone high-tech. From a branded exterior to a custom shot clock, Yupelri’s sponsorship activation was a slam dunk success. Up to four attendees at once faced off in a 60 second competition featuring two game modes.
ATS attendees enjoyed a new twist on air hockey, featuring a high-tech round surface designed for up to four players. Rather than playing for points like in the classic version, Quad Hockey is a game of elimination. Each time a puck enters a goal, a light illuminates. Once a player’s three lights are illuminated, they are eliminated from the game and the remaining players continue in a game of survival.
It doesn’t get much more classic than foosball. ATS attendees twisted and slid the metal rods to score on their opponent’s goal.
About The American Thoracic Society (ATS)
The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.
The ATS International Conference is the home of pulmonary, critical care, and sleep professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.
YUPELRI is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD), a long-term (chronic) lung disease that includes chronic bronchitis, emphysema, or both.